Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576537 · ClinicalTrials.gov registry record · Phase 2
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
A Phase 2 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00576537: Completed Phase 2 study, sponsored by Cedars-Sinai Medical Center.
NCT00576537 is a Phase 2 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00576537, a Phase 2 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This research is being determine whether vaccinations with your own immune cells called " dendritic cells " can activate your immune system to fight your brain tumor.
Primary Outcome
Cytotoxic T lymphocyte (CTL) precursor frequency
Interventions
- BIOLOGICAL Dendritic Cell Immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2001-03 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
What the finished NCT00576537 record still lists
NCT00576537 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 1 intervention - of which Dendritic Cell Immunotherapy is the first listed.
NCT00576537 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00576537 about?
NCT00576537 is a clinical study titled "Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors". This research is being determine whether vaccinations with your own immune cells called " dendritic cells " can activate your immune system to fight your brain tumor.
What is the current status of trial NCT00576537?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2001-03. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00576537?
The interventions under investigation include: Dendritic Cell Immunotherapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT00576537?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00576537's enrollment target sits among peer trials
50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia